Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain
AbbVie (NYSE: ABBV) Delayed: 230.01 +13.52 (6.25%)
Previous Close $216.49    52 Week High $68.12 
Open $221.94    52 Week Low $50.71 
Day High $232.32    P/E 49.89 
Day Low $221.94    EPS $4.61 
Volume 9,912,419